YEAR
- 2011.11.17 Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis. Tsuji S, Midorikawa Y, Takahashi T, Yagi K, Takayama T, Yoshida K, Sugiyama Y, Aburatani H.Br. J. Cancer. 2012 Jan 03;106(1):126-32. doi: 10.1038/bjc.2011.505
- 2011.11.21 Oxidation of DJ-1 induced by 6-hydroxydopamine decreasing intracellular glutathione. Miyama A, Saito Y, Yamanaka K, Hayashi K, Hamakubo T, Noguchi N.PLoS ONE. 2011;6(11):e27883. doi: 10.1371/journal.pone.0027883
- 2011.11.27 Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer. Fujimura T, Takahashi S, Urano T, Tanaka T, Zhang W, Azuma K, Takayama K, Obinata D, Murata T, Horie-Inoue K, Kodama T, Ouchi Y, Homma Y, Inoue S.Cancer Sci. 2012 Feb;103(2):176-80. doi: 10.1111/j.1349-7006.2011.02143.x
- 2011.12.05 Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis. Osawa T, Muramatsu M, Wang F, Tsuchida R, Kodama T, Minami T, Shibuya M.Proc. Natl. Acad. Sci. U.S.A. 2011 Dec 20;108(51):20725-9. doi: 10.1073/pnas.1108462109
- 2011.12.05 Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kasai M, Ichimura T, Sudo T, Tagawa Y, Nishimura R, Ishiko O, Kanai Y, Yaegashi N, Aburatani H, Shiozawa T, Konishi I.Sci Rep. 2011;1:180. doi: 10.1038/srep00180
- 2011.12.07 Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Wang L, Tsutsumi S, Kawaguchi T, Nagasaki K, Tatsuno K, Yamamoto S, Sang F, Sonoda K, Sugawara M, Saiura A, Hirono S, Yamaue H, Miki Y, Isomura M, Totoki Y, Nagae G, Isagawa T, Ueda H, Murayama-Hosokawa S, Shibata T, Sakamoto H, Kanai Y, Kaneda A, Noda T, Aburatani H.Genome Res. 2012 Feb;22(2):208-19. doi: 10.1101/gr.123109.111
CLOSE